XML 61 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Accrued Liabilities Current [Abstract]    
Preclinical and clinical trial accruals $ 65,112 $ 56,283
API and bulk drug product price true-up 60,834
Acquired in-process research and development asset 35,000
Payroll and related accruals 12,325 20,909
Contract liabilities to pharmaceutical distributors 2,759 3,176
Accrued co-promotion expenses - current 28,117 25,746
Roxadustat profit share to AstraZeneca 7,917 7,895
Property taxes and other taxes 13,928 12,610
Professional services 6,819 6,074
Other 5,488 4,906
Total accrued and other current liabilities $ 203,299 $ 172,599